Accéder au contenu
Merck

HPLC Analysis of Nucleosides on Ascentis® Express OH5 (HILIC Mode)

HPLC Analysis of Nucleosides on Ascentis® Express OH5 (HILIC Mode) application for HPLC

Matériaux

Colonne analytique

Réf. du produit
Description
Tarif

Ascentis® Express OH5, 2.7 μm HPLC Column

2.7 μm particle size, L × I.D. 10 cm × 2.1 mm

Étalon

Réf. du produit
Description
Tarif

Mélange test de nucléosides

in 1% sodium formate (varied conc.), analytical standard

Adenosine

Pharmaceutical Secondary Standard; Certified Reference Material

Disodium Guanylate

Pharmaceutical Secondary Standard; Certified Reference Material

Uridine

Pharmaceutical Secondary Standard; Certified Reference Material

Guanosine

Pharmaceutical Secondary Standard; Certified Reference Material

5′-Adenylic Acid

Pharmaceutical Secondary Standard; Certified Reference Material

Thymidine

pharmaceutical secondary standard

Cytidine

certified reference material, pharmaceutical secondary standard

CONDITIONS

column

Ascentis Express OH5, 10 cm x 2.1 mm I.D., 2.7 μm particles (53757-U)

mobile phase

[A] 5 mM ammonium acetate, pH 5.0 with acetic acid in 95:5, acetonitrile:water; [B] 5 mM ammonium acetate, pH 5.0 with acetic acid in 80:20, acetonitrile:water

gradient

0% B held for 1 min; to 100% B in 10 min; held at 100% B for 1 min

flow rate

0.3 mL/min

column temp.

25 °C

detector

UV, 250 nm

injection

2 μL

sample

10 - 100 μg/mL in 95:5, acetonitrile:water (pH of buffer stock (in water) was adjusted before further dilution with water and/or acentonitrile)

Description

Remarque sur l'analyse

Nucleosides are involved in many aspects of metabolism. Analogs of nucleosides have medical application in antivirals or anticancer treatments. This application demonstrates the utility of hydrophilic interaction chromatography (HILIC) for the retention and resolution of nucleosides and analogs thereof. Elution is not solely explained by logD but by other ionic and solvophobic effects.

Informations légales

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany